OT-7100
OT-7100 is an orally active analgesic agent. OT-7100 inhibits hyperalgesia possibly by enhancing adenosinergic neurotransmission in the dorsal horn. OT-7100 can be used for the researches of inflammation, neurological and metabolic disease such as diabetes2].
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 174858-27-6
- Formel: C20H24N4O4
- Molecular Weight:384.43
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Adenosine Receptor Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
In Vitro
In Vivo
OT-7100 (10-100 mg/kg, p.o., daily for 21 days) increases the nociceptive threshold in diabetic rats[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 174858-27-6
-
Molecular Weight 384.43
-
Formel C20H24N4O4
-
SMILES
O=C(C1=CC(OC)=C(OC)C(OC)=C1)NC2=CC(CCCC)=NC3=CC=NN23
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Yasuda T, et al. A novel analgesic compound OT-7100 attenuates nociceptive responses in animal models of inflammatory and neuropathic hyperalgesia: a possible involvement of adenosinergic anti-nociception. Jpn J Pharmacol. 2001 Nov;87(3):214-25. [Content Brief]
[2]. Miki S, et al. Antinociceptive effect of the novel compound OT-7100 in a diabetic neuropathy model. Eur J Pharmacol. 2001 Nov 2;430(2-3):229-34. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)